New York, NY, March 11th, 2019 – The global Orthobiologics Market was valued at over US$ 5.5 Bn. in 2017 and is expected to grow at a considerable CAGR during the forecasted period.

Market Industry Reports (MIR) has recently updated its massive report catalogue by adding a fresh study titled “Orthobiologics Market Analysis & Evolving Opportunities Studied for the Period Until 2030”. This business intelligence study encapsulates vital details about the market current as well as future status during the mentioned forecast period of 2030.The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated to growth of manufacturers in global market for (Orthobiologics Market). Along with these insights, the report provides the readers crucial insights on the strategies implemented by leading companies to remain in the lead of this competitive market.

The Study On Major Key Players in the Orthobiologics Market are Medtronic, DePuy Synthes, Zimmer Biomet, MTF, Sanofi, Bioventus, Arthrex, Seikagaku and NuVasive among others.

The growth of this market can be attributed to the factors such as, increase in sports injuries and road accidents, awareness among patients & athletes, rise in obesity rate, and continuously aging population. According to the World Health Organization, 2017, fatal road accidents are the second primary cause of factures and accidental injury worldwide with almost 646000 individuals die every year around the world.

Lack of reimbursement to hinder the market growth
Regulatory directives for treatment of hip replacement and knee surgery and lack of reimbursement policies are expected to delay growth in the orthobiologics market. However, the market offers profit-making prospects, especially in the developed regions where incidence of arthritis and obesity is particularly high. Demand for the minimally invasive procedures is witnessed to grow due to the rise of various diseases and bone disorders.
Key players are focusing on new product development as the major market strategy
The companies are extensively integrating new product development activities, distribution enhancement strategies, collaborations, mergers & acquisitions and frequent product approval. For instance, in 2016, NuVasive Inc. launched AttraX Putty, its next generation biologics technology. It is an artificial bone graft, specified in posterolateral spinal surgery, as autograft extender. The product launch was approved to gain competitive advantage and also to expand the product portfolio to differentiate form the other market players.

This Orthobiologics market report holds answers to some important questions like:

– What is the size of occupied by the prominent leaders for the forecast period, 2019 to 2030? What will be the share and the growth rate of the Orthobiologics market during the forecast period?
– What are the future prospects for the Orthobiologics industry in the coming years?
– Which trends are likely to contribute to the development rate of the industry during the forecast period, 2019 to 2030?
– What are the future prospects of the Orthobiologics industry for the forecast period, 2019 to 2030?
– Which countries are expected to grow at the fastest rate?
– Which factors have attributed to an increased sale worldwide?
– What is the present status of competitive development?

Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.